Related Experiment Videos
The Burrow Ink Test and the scabies mite
Journal of the American Academy of Dermatology
|June 1, 1981
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.
The British journal of dermatology·2014
Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.
Dermatology (Basel, Switzerland)·2008
Management of psoriasis: the position of retinoid drugs.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
A toxicologic and dermatologic assessment of related esters and alcohols of cinnamic acid and cinnamyl alcohol when used as fragrance ingredients.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2007
A toxicologic and dermatologic assessment of ionones when used as fragrance ingredients.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2007
A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2007
Clinical outcomes associated with a digital standardized skin care regimen in acne-rosacea comorbidity: A real-world longitudinal study with cross-lagged and mediation analyses.
Journal of the American Academy of Dermatology·2026
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison.
Journal of the American Academy of Dermatology·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026